<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04974450</url>
  </required_header>
  <id_info>
    <org_study_id>1007210708</org_study_id>
    <nct_id>NCT04974450</nct_id>
  </id_info>
  <brief_title>Trigona Honey and Intestinal Microbiota Among Obese People</brief_title>
  <official_title>Effect of Trigona Honey to Intestinal Microbiota, Lipid Profile and Anthropometric Status in Obese Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasanuddin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hasanuddin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective :&#xD;
&#xD;
      Nutrition intervention is one of the approaches to deal with obesity. Natural honey with its&#xD;
      polyphenol component has an impact on the intestinal microbiota and lipid profile. Intestinal&#xD;
      microbiota such as lactobacillus and bifidobacteria produce exopolysaccharide which plays&#xD;
      important roles against obesity. This research aims to assess the effect of Trigona biroi&#xD;
      honey on body mass index, lipid profile, and microbiota profile&#xD;
&#xD;
      Design A Quasi-experimental study involving two arms (trigona honey) and control will be&#xD;
      conducted. The outcome of interests are body mass index, lipid profile, and microbiota&#xD;
      profile&#xD;
&#xD;
      Hypothesis using superiority trial, trigona honey will&#xD;
&#xD;
        1. improve microbiota (increase lactobacillus and bifidobacteria and reduce clostridium)&#xD;
&#xD;
        2. Improving lipid profile&#xD;
&#xD;
        3. lowering body mass index&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Target population :&#xD;
&#xD;
      This study will recruit healthy participants with a body mass index of more than 27&#xD;
&#xD;
      allocation : non-random with propensity score matching&#xD;
&#xD;
      Arms&#xD;
&#xD;
        1. Trigona honey (intervention) composition : vitamin C 0.15%, Protein 1.32%, lipid 0.23%,&#xD;
           carbohydrate 64.12%, beta carotene 10.61 ppm, Calcium 273,23, magnesium 338.94, zinc&#xD;
           12.49 ppm, and acidity 5.76. Total polyphenol 133.52 ppm, total flavonoid 159.62 ppm.&#xD;
           This liquid has a sour profile&#xD;
&#xD;
        2. Active comparator Commercial honey with fructose, Glucose, pure honey (2,271%), citric&#xD;
           acid, and lime extract (0,076%).&#xD;
&#xD;
      Intervention 8 weeks, once daily. This also applied to the control group&#xD;
&#xD;
      Outcome :&#xD;
&#xD;
        1. Microbiota detected using Polymerase Chain Reaction (PCR)&#xD;
&#xD;
             1. Sample: Stool&#xD;
&#xD;
             2. extraction with 70% ethanol primary PCR&#xD;
&#xD;
             3. primer (Lactobacillus and bifidobacteria)&#xD;
&#xD;
        2. Lipid Profile using blood plasma and homogenous assay High-Density Lipoprotein,&#xD;
           Low-Density Lipoprotein, Triglyceride, total cholesterol&#xD;
&#xD;
        3. Anthropometry Body mass index, body composition (fat percentage), waist circumference&#xD;
&#xD;
      Sample Size was calculated using the difference of HDL between groups with the following&#xD;
      parameters :&#xD;
&#xD;
      Effect size =0.3 Type 1 error = 5% Power of Study = 80% dropout = 20% total participant 336&#xD;
&#xD;
      Analysis Intention to treat will be applied. The descriptive statistic will be used to&#xD;
      describe the baseline characteristic of participants. The bivariate analysis will be&#xD;
      conducted to see the association of demographic factors to the outcome. If the matching of&#xD;
      the participant yields a similar baseline characteristic, the difference of mean between the&#xD;
      two groups will be analyzed using an independent t-test. Otherwise, linear mixed model will&#xD;
      be applied&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two different groups will be given two different honey. In the intervention group, trigona honey will be administered for 8 weeks whereas the control group will be given artificial honey that has a similar taste and appearance to the intervention group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Masking in terms of taste and appearance is applied to yield a similar product. Researchers prepare artificial honey formula with citrus flavor to mimic the natural taste of trigona honey. Neither the care provider nor the investigator aware of the allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Level of intestinal microbiota in stool</measure>
    <time_frame>Changes of microbiota level from day 0 to day 60 after intervention</time_frame>
    <description>the level of bifidobacteria, clostridium, and lactobacillus (in colony factor unit/grams) in stool measured using polymerase chain reaction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>Changes of body mass index from day 0 to day 60 after intervention</time_frame>
    <description>measured by dividing body weight in kilogram per square meter of height</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid Profile</measure>
    <time_frame>Changes of lipid profile from day 0 to day 60 after intervention</time_frame>
    <description>the level of High-Density Lipoprotein, Low-density lipoprotein, total cholesterol and triglyceride in blood plasma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Trigona Honey</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention will be given by oral route in a form of liquid of 70-gram trigona honey once daily for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intervention will be given by oral route in a form of liquid of 70-gram artificial honey once daily for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Trigona honey</intervention_name>
    <description>composition : vitamin C 0.15%, Protein 1.32%, lipid 0.23%, carbohydrate 64.12%, beta carotene 10.61 ppm, Calcium 273,23, magnesium 338.94, zinc 12.49 ppm, and acidity 5.76. Total polyphenol 133.52 ppm, total flavonoid 159.62 ppm. This liquid has a sour profile</description>
    <arm_group_label>Trigona Honey</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>control</intervention_name>
    <description>Artificial honey with fructose, Glucose, pure honey (2,271%), citric acid, and lime extract (0,076%).</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Defined as obese with a body mass index of more than 27&#xD;
&#xD;
          2. Not having a gastrointestinal disease&#xD;
&#xD;
          3. Not allergic to the honey component&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Consuming probiotics for a minimum of one month&#xD;
&#xD;
          2. Consuming antibiotics for a minimum of one month&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andi S Rahma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hasanuddin University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andi S Rahma, MD</last_name>
    <phone>+6285242714698</phone>
    <email>andisittirahma@yahoo.co.id</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wahidin Sudirohusodo General Hospital</name>
      <address>
        <city>Makassar</city>
        <state>South Sulawesi</state>
        <zip>76124</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andi S Rahma, MD</last_name>
      <phone>+625242714698</phone>
      <email>andisittirahma@yahoo.co.id</email>
    </contact>
    <investigator>
      <last_name>Andi S Rahma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>de Melo FHC, Menezes FNDD, de Sousa JMB, Dos Santos Lima M, da Silva Campelo Borges G, de Souza EL, Magnani M. Prebiotic activity of monofloral honeys produced by stingless bees in the semi-arid region of Brazilian Northeastern toward Lactobacillus acidophilus LA-05 and Bifidobacterium lactis BB-12. Food Res Int. 2020 Feb;128:108809. doi: 10.1016/j.foodres.2019.108809. Epub 2019 Nov 21.</citation>
    <PMID>31955768</PMID>
  </reference>
  <reference>
    <citation>Jiang L, Xie M, Chen G, Qiao J, Zhang H, Zeng X. Phenolics and Carbohydrates in Buckwheat Honey Regulate the Human Intestinal Microbiota. Evid Based Complement Alternat Med. 2020 Feb 26;2020:6432942. doi: 10.1155/2020/6432942. eCollection 2020.</citation>
    <PMID>32184894</PMID>
  </reference>
  <reference>
    <citation>Lashani E, Davoodabadi A, Soltan Dallal MM. Some probiotic properties of Lactobacillus species isolated from honey and their antimicrobial activity against foodborne pathogens. Vet Res Forum. 2020 Spring;11(2):121-126. doi: 10.30466/vrf.2018.90418.2188. Epub 2020 Jun 15.</citation>
    <PMID>32782740</PMID>
  </reference>
  <reference>
    <citation>Mohd Rafie AZ, Syahir A, Wan Ahmad WAN, Mustafa MZ, Mariatulqabtiah AR. Supplementation of Stingless Bee Honey from Heterotrigona itama Improves Antiobesity Parameters in High-Fat Diet Induced Obese Rat Model. Evid Based Complement Alternat Med. 2018 Nov 21;2018:6371582. doi: 10.1155/2018/6371582. eCollection 2018.</citation>
    <PMID>30643535</PMID>
  </reference>
  <reference>
    <citation>Samat S, Kanyan Enchang F, Nor Hussein F, Wan Ismail WI. Four-Week Consumption of Malaysian Honey Reduces Excess Weight Gain and Improves Obesity-Related Parameters in High Fat Diet Induced Obese Rats. Evid Based Complement Alternat Med. 2017;2017:1342150. doi: 10.1155/2017/1342150. Epub 2017 Jan 26.</citation>
    <PMID>28246535</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasanuddin University</investigator_affiliation>
    <investigator_full_name>Bumi Herman</investigator_full_name>
    <investigator_title>Assistant Lecturer</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>trigona honey</keyword>
  <keyword>lipid profile</keyword>
  <keyword>microbiota</keyword>
  <keyword>anthropometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>de-identified data will be shared accordingly</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

